BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37455549)

  • 1. The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
    Zagami P; Comandone A; Fiore M; Baldi GG; Grignani G; Vincenzi B; Gronchi A; Antonarelli G; Boglione A; Pennacchioli E; Curigliano G; Conforti F; De Pas TM
    Cancer Med; 2023 Aug; 12(16):17047-17055. PubMed ID: 37455549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors and leiomyosarcomas.
    Katz SC; DeMatteo RP
    J Surg Oncol; 2008 Mar; 97(4):350-9. PubMed ID: 18286477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
    Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
    Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments.
    Smrke A; Benson C; Strauss DC; Hayes AJ; Thway K; Hallin M; Fisher C; Messiou C; Huang PH; Jones RL; Smith MJ
    Eur J Surg Oncol; 2021 Oct; 47(10):2595-2601. PubMed ID: 33966946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?
    Colombo C; Miceli R; Collini P; Radaelli S; Palassini E; Stacchiotti S; Fiore M; Mariani L; Casali PG; Gronchi A
    Cancer; 2012 Nov; 118(21):5349-57. PubMed ID: 22517186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.
    Hilal L; Barada K; Mukherji D; Temraz S; Shamseddine A
    Med Oncol; 2016 Feb; 33(2):20. PubMed ID: 26786155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications.
    Pérez-Gutiérrez S; González-Cámpora R; Amérigo-Navarro J; Beato-Moreno A; Sánchez-León M; Pareja Megía JM; Virizuela-Echaburu JA; López-Beltrán A
    Pathol Oncol Res; 2007; 13(3):203-8. PubMed ID: 17922049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
    Akin S; Dizdar O; Karakas Y; Turker A; Kars A
    Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 11. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.
    Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY
    J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)
    Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY
    Ann Oncol; 2021 Apr; 32(4):533-541. PubMed ID: 33482247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic uterine leiomyosarcomas: a single-institution experience.
    Bernstein-Molho R; Grisaro D; Soyfer V; Safra T; Merimsky O
    Int J Gynecol Cancer; 2010 Feb; 20(2):255-60. PubMed ID: 20134269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large national comparative study of clinicopathological features and long-term survivals between esophageal gastrointestinal stromal tumor and leiomyosarcoma.
    Azab B; Macedo FI; Cass SH; Ripat C; Razi SS; Picado O; Franceschi D; Livingstone AS; Yakoub D
    Am J Surg; 2019 Aug; 218(2):323-328. PubMed ID: 30471808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
    Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
    Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
    Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
    Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
    Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison.
    Clary BM; DeMatteo RP; Lewis JJ; Leung D; Brennan MF
    Ann Surg Oncol; 2001 May; 8(4):290-9. PubMed ID: 11352301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.